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Edited by Hans-Dieter KlenkAbstract Cell infection by alphaviruses is accompanied by
membrane permeability changes. New predictive approaches,
including the computation of interfacial aﬃnity and correspond-
ing hydrophobic moments, suggest a segmented amphipathic-at-
interface domain in the stem region of Semliki Forest virus
fusion protein E1. Expression of E1 sequences in Escherichia coli
cells conﬁrmed that the membrane proximal plus transmembrane
(TM) domain unit permeabilizes cells as eﬃciently as the 6K
viroporin. Both our predictive and experimental data support the
involvement of the E1 stem-TM region in membrane insertion
and permeabilization. We propose to combine Wimley–White
hydrophobicity analysis with expression-coupled permeability
assays in order to identify viral products implied in breaching cell
membrane barriers during infection.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pre-transmembrane1. Introduction
Alphavirus infection modiﬁes membrane permeability at
two well-deﬁned stages, early and late in the lytic cycle [1–4].
Early membrane modiﬁcations are provoked by the entry of
the virus particles in a process that does not require viral gene
expression, since it is the virion glycoproteins that are re-
sponsible for early membrane leakiness. Small molecules, as
well as proteins, eﬃciently co-enter with virus particles during
the entry of alphaviruses [5,6]. Late modiﬁcations lead to an
imbalance of ions in the cytoplasm, thus blocking host protein
synthesis [3,4,7,8]. The translation of Semliki Forest virus
(SFV) subgenomic 26S mRNA is not inhibited by high
monovalent ion concentrations, either in vitro or in infected
cells [9,10]. Evidence for membrane permeabilization by al-
phavirus glycoproteins has been obtained by measuring the
release of [3H]choline from the interior of liposomes in the
presence of virus particles and viral proteins [11]. Comple-
mentarily, through electrophysiological measurements, the* Corresponding author. Fax: +34-94-601-3360.
E-mail address: gbpniesj@lg.ehu.es (J.L. Nieva).
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membrane of cells infected with Sindbis or SFVs can be de-
tected [4,11]. Although not formally proven, there is evidence
to suggest that E1 is the glycoprotein with pore-forming ca-
pacity in alphaviruses. Pore formation has been detected in
proteolytically modiﬁed single virions maintaining E1 spike
component [12]. Individual expression of alphavirus E1 gly-
coprotein induces animal cell fusion [13] and pore formation in
bacteria [14]. Moreover, its structural homolog, ﬂavivirus E
protein, has also been shown to form ion permeable pores [15].
Early results obtained from our laboratory led to the sug-
gestion that the 6K product might be involved in membrane
permeabilization at late stages of alphavirus infection. Induc-
ible expression of the 6K gene in Escherichia coli cells
enhanced membrane permeability to hygromycin B and 3H-
choline [16]. Further analysis of 6K interfacial hydrophobicity
revealed the presence of two stretches containing invariant Trp
residues within the 6K protein ectodomain, exhibiting a high
tendency to partition into membrane interfaces [17]. Integra-
tion of 6K within the membrane was insuﬃcient for membrane
destabilization, the interfacial N-terminal region also being
required for membrane permeabilization. A model was pro-
posed according to which a sequence embedded in the mem-
brane interface followed by the transmembrane (TM) anchor
represents the minimal structure needed for functional 6K to
induce membrane alterations. Again, a similar organization
including interfacial helices followed by a TM domain has
been described for the stem region of ﬂavivirus E protein [18].
In fact, the structure of mature dengue virus particles deter-
mined by cryo-electron microscopy and image reconstruction
reveals that the a-helical stem regions of the E molecules are
buried in the outer leaﬂet of the viral membrane [19].
Recently obtained X-ray diﬀraction data have revealed the
three-dimensional structure of SFV E1 glycoprotein lacking
the stem-TM regions [20]. Herein, we have used newly devel-
oped Wimley–White (WW) scales to analyze hydrophobicity
distribution along the crystallographically unsolved SFV E1
elements [21–23]. Our analysis suggests the existence of one
segmented membrane-interface associating helix within the
stem region, which hypothetically represents a membrane-
active site on E1. The inducible expression indicates that the
interfacial pre-transmembrane region followed by the TM
domain combines to establish a permeabilizing motif at the
carboxy terminus of the protein. This region might well par-
ticipate in the fusion reaction, either as a general destabilizer of
bilayer architecture and/or as a creator of a pore-containing
bilayer destined for fusion. A similar approach combining
prediction with expression-coupled permeability assaysblished by Elsevier B.V. All rights reserved.
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identify products and sequences involved in host membrane
destabilization.Fig. 1. Hydrophobicity distribution within the E1 stem-transmem-
brane region. Top: Schematic diagram of SFV E1 showing the location
of constituent folding domains and the membrane-interacting FP
(fusion peptide) and TM (transmembrane) regions. The WW hy-
dropathy analysis below comprises the stem (hatched box) and TM
(black box) regions. Black: TM helix propensity (mean standard free
energies of transfer from octanol to water in windows of 11 residues);
gray: interfacial hydrophobicity (mean free energies of transfer from
membrane interfaces to water in windows of ﬁve amino acids); white:
average interfacial hydrophobic moment for ﬁxed d ¼ 100 and win-
dows of ﬁve amino acids. Cylinders on top of the plot indicate the
predicted elements: membrane-interface embedded amphipathic heli-
ces (hatched) and the TM helical anchor combining interfacial regions
(white) with the hydrocarbon core spanning region (black). The bot-
tom plot corresponds to the turn propensity within the stem-TM re-
gion. Normalized turn potentials described by Monne et al. [30] for
TM sequences were used to calculate average values within sliding
windows of ﬁve amino acids.2. Materials and methods
2.1. Calculating hydrophobic moments
To compute the hydrophobic-at-interface moment, we considered
membrane interface-to-water transfer free energies (DGiwu) for each
amino acid [22,24] as the moduli of the vectors that project from the
main axes of the secondary structure element, following the direction
of the amino acid side chains [25]. The hydrophobic moment (lH) of a
sequence of N residues was then calculated as the addition of the N
hydrophobicity vectors corresponding to the constituent amino acids,
according to the equation [25,26]:
lH ¼
XN
n¼1
Hn sinðdnÞ
 !20@ þ XN
n¼1
Hn cosðdnÞ
 !21A
1=2
;
where Hn is the hydrophobicity of the n residue and d is the angle
formed between side chains of consecutive residues, i.e., 100 for he-
lical conformations.
2.2. Bacterial expression and permeability changes
DNA manipulations were performed following standard cloning
techniques as previously described [16,27]. Brieﬂy, the polymerase
chain reaction (PCR) was used to amplify the E1 gene from
pGEM1.SFV plasmid (kindly provided by Dr. P. Liljestrom, Karo-
linska Institute). Oligonucleotides were designed to include codons to
stop and initiate translation and to create NdeI and BamHI restriction
sites. PCR products were puriﬁed, analyzed by agarose gel electro-
phoresis and subsequently ligated with dephosphorylated pET11b
vector (kindly provided by B.A. Moﬀat and F.W. Studier, Brookhaven
National Laboratory, NY). The ligation mixtures were used to trans-
form DH5-competent E. coli cells. The resulting colonies were screened
by digestion with the appropriate restriction enzymes. The region of
the plasmids containing the E1 sequences was sequenced by the dide-
oxy method prior to transforming BL2l(DE3) pLysS E. coli cells.
Transformed cells were grown overnight at 37 C in Luria–Bertani
medium in the presence of 100 lg/ml ampicillin and 34 lg/ml chlor-
amphenicol. The cells were then diluted 100-fold in M9 medium sup-
plemented with 0.2% glucose, 2 mMMgSO4, and 0.1 mM CaCl2. Once
the cultures reached ca. 0.6 units of absorbance at 660 nm, they were
induced by the addition of 1 mM isopropyl-b-D-thio-galactopyrano-
side (IPTG) (Boehringer Mannheim). 20 min after IPTG addition, the
medium was supplemented with 150 lg/ml rifampicin (Boehringer
Mannheim) to inhibit transcription by E. coli RNA polymerase. Pro-
teins synthesized after culture induction were labeled by placing 1-ml
aliquots in tubes containing 1 lCi of [35S]methionine (1.45 Ci/mmol,
Amersham Corp.) followed by incubation for 15 min at 37 C. The
labeled bacteria were centrifuged for 1 min at 12 000 rpm in an Ep-
pendorf microcentrifuge and dissolved in lysis buﬀer (17% glycerol,
0.1 M dithiothreitol, 0.37 M Tris–HC1, pH 6.8, 1% SDS and 0.024%
bromphenol blue). The samples were electrophoresed in 0.1% SDS,
20% polyacrylamide gels. Fluorography was conducted by incubation
of the gel with 1 M salicylic acid for 1 h. After drying, the gels were
exposed to X-ray ﬁlms at )70 C.
To determine changes in membrane permeability, two alternative
procedures were followed: (1) protein synthesis inhibition by hygro-
mycin B entry and (2) measurement of radioactivity released from
[3H]choline or [3H]uridine-preloaded cells. In the ﬁrst procedure, cells
routinely induced for 1 h. were labeled as described with [35S]methionine
for 15min in the presence or the absence of 1mMhygromycinB (Sigma).
Protein production was subsequently analyzed through SDS–PAGE
and ﬂuorography. In the second procedure, bacterial cultures grown
overnight were diluted in 10–20 ml of M9 medium containing 2 lCi/ml
[3H]choline chloride (80 Ci/mmol, Amersham Corp.) or [3H]uridine
(60 Ci/mmol, Amersham Corp.) and incubated for 1 h. The cells were
then centrifuged for 2 min at 3000 rpm and washed in freshM9medium
three times. Half of the culture (5–10 ml) was induced as described
above. At diﬀerent times, 200 l1 of bacteria was centrifuged at 3000 rpm
and the supernatants were mixed with L-929 scintillation mixture (Du-
Pont) to quantify the radioactivity released into the medium.3. Results and discussion
The upper diagram in Fig. 1 illustrates the structural orga-
nization of the E1 protein. An amino-terminal globular b-type
structure combines domains I and II, which are followed by
immunoglobulin-like domain III. The rest of the sequence in-
cluding the stem and TM regions is absent from the crystals
solved by X-ray diﬀraction [20]. Hydrophobicity analysis of
the unsolved region is shown in the bottom panels. Average
hydropathy plots were calculated according to the so-called
WW octanol (black) and hydrophobicity-at-interface (gray)
scale [28].
The WW octanol scale provides a reasonable estimate of the
free energy of inserting a-helical TMDs into bilayers [23,29].
The hydropathy plot displayed in black was computed using
octanol-to-water partitioning free energies (DGow), i.e., posi-
tive values in the plot denote a tendency to remain in the
Fig. 2. Expression of E1 sequences in E. coli (BL21(DE3) pLysS) and
their membrane-permeabilizing activity. (A) Schematic diagrams of
expressed E1 sequences. (B) Left panel: ﬂuorographic analysis of SFV
E1 proteins synthesized in E. coli (BL21(DE3) pLysS strain) from re-
combinant pET11b plasmids. Bacteria were induced with 1 mM IPTG
(time 0) and supplemented with 150 lg/ml rifampicin 20 min after
induction. Proteins were labeled at the indicated times with 1 lCi/ml
[35S]methionine for 15 min. Right panel: Expression at membranes.
The cultures were induced for 60 min, labeled with [35S]methionine and
processed for the analysis of membrane fractions: Deb: pellet fraction
of cell lysates centrifuged at 10 000 g was collected, solubilized with
lysis buﬀer and subjected to SDS–PAGE (see Section 2); Supernatants
obtained in the previous centrifugation were subjected to ultracen-
trifugation at 100 000 g. Sol: samples collected from supernatant
fraction; Mb: idem, but recovered from pellet fraction. (C) Membrane
permeabilization according to hygromycin B entry and release of
[3H]uridine or [3H]choline. Hygromycin-B entry was estimated
through ﬂuorographic analysis from the relative reduction in protein
band intensity and area in samples treated with the antibiotic. Ex-
pression of XA, a 32-kDa non-toxic protein from phage T7, served as
control. Bars represent means of three independent measurements plus
standard deviations.
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conﬁrms the occurrence of a prominent peak above the 0
equilibrium value (residues 418–432), which would roughly
correspond to the membrane anchor spanning the hydrocar-
bon nucleus as an a-helix. On the other hand, average inter-
facial hydrophobicity reﬂects a tendency to remain associated
with membrane interfaces. Average membrane interface-to-
water partitioning free energy (DGiw) values (gray plot) fail to
reﬂect a signiﬁcant tendency to locate at membrane interfaces
within E1 sequences of the stem-TM region. However, com-
putation of the corresponding hydrophobic-at-interface mo-
ment for this region reveals the presence of unnoticed
membrane-interface associating sequences (white plot). Hy-
drophobic moments measure the periodicity of residue distri-
bution along secondary structure elements [25,26]. Preferential
orientation of the hydrophobic-at-interface residues towards
one side of the structure element (amphipathicity-at-interface)
is thought to promote the embedding of protein sequences at
membrane interfaces [22,24]. The average hydrophobic mo-
ment computed using membrane interface-to-water transfer
free energies (DGiwu) and ﬁxed d ¼ 100 detected two main
peaks, comprising 10 amino acids each within the pre-
transmembrane region. This reﬂects a tendency to segregate
pre-transmembrane residues into deﬁned surfaces of interfacial
a-helices. Thus, the particular moment distribution suggests
that the E1 preTM might interfacially associate with mem-
branes adopting a segmented amphipathic helical structure.
Smaller peaks before and after the octanol peak might
represent the boundaries of the TM domain.
In conclusion, the hydrophobicity distribution analysis
shown in Fig. 1 suggests the most favorable organization at the
stem-TM region of E1 glycoprotein (diagram top) to be: two
amphipathic-at-interface a-helices (residues 390–403 and 404–
414), preceding a domain that transverses the viral membrane
bilayer (residues 415–438), embedded in the external mono-
layer. Further support for this segmented organization is
provided by the distribution within this region of a tendency to
adopt interfacial turns (bottom panel) calculated according to
the scale described by Monne et al. [30]. The dominance of a
turn-inducing tendency (normalized turn potential >1) over a
non-inducing one (turn potential <1) is clearly noticeable at
positions 400–403 and 412–414.
Based on this prediction, we experimentally characterized
the ability of the E1 membrane-proximal region to permea-
bilize bacterial cells. To this end, we made use of a standard
assay developed by our group, in which the Studier system for
the expression of toxic proteins in E. coli [31–33] is combined
with measurements of cell membrane permeability changes
coupled to recombinant protein expression [16,34]. Fig. 2
shows cloned E1 sequences (panel A), their expression fea-
tures (panel B) and their capacity to increase membrane
permeability (panel C). In the presence of IPTG and rifam-
picin, pET11 E1 sequences were the products almost exclu-
sively expressed by cultures. Full E1 protein could be
recovered from membrane fractions and its expression re-
sulted moderately toxic as inferred from the decay in protein
synthesis with time (panel B). Expression of a single stem-TM
domain (E1C) proved to be extremely toxic and could also be
detected in association with membrane fractions. Removal of
the E1C region to generate E1ecto rendered a product of
lower toxicity that could not be detected when associated to
membranes.Results shown in panel C are consistent with the involve-
ment of the stem-TM domain in cell permeabilization. This
activity can be detected using compounds such as hygromycin
B, choline or uridine, as occurs with mammalian cells infected
with SFV [2]. The inhibition of protein synthesis by the ami-
noglycoside antibiotic hygromycin B constitutes a sensitive test
for assaying membrane permeability modiﬁcations in intact
cells [16,34]. The antibiotic did not cross the membrane of
induced E. coli cells transformed with control non-
recombinant pET11b plasmids (not shown) or cells that ex-
pressed high levels of recombinant XA protein. Thus, massive
protein synthesis or the presence of the expression inducers
was insuﬃcient to trigger hygromycin B entry into cells. In
contrast, isolated E1 expression allowed hygromycin B entry,
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extremely potent at inducing entry of hygromycin B into cells.
Release of compounds from cells preloaded with [3H]choline
or [3H]uridine was also maximal for cells expressing the E1C
product. Full-length E1-expressing cells showed an interme-
diate eﬀect, while cells that synthesize E1ecto devoid of stem-
TM sequence were less permeable. In conclusion, the capacity
to insert into membranes (panel B) and permeabilize them
(panel C) seems to speciﬁcally locate at the stem-TM E1 re-
gion. Of note, E2 expression controls did not alter membrane
permeability (data not shown), suggesting that permeabilizing
activity may be solely associated to the E1 spike component of
SFV.
Experiments depicted in Fig. 3 were designed to demonstrate
that E1C-induced permeabilization reﬂects an intrinsic and
speciﬁc activity of this product. To this end, a construct en-
coding SFV E1 TMD (residues 414–438) was generated. Ex-
pression of the isolated TME1 product was possible after
IPTG/rifampicin induction. Comparable cell lysis was ob-
served upon induction of TME1 and E1C, suggesting that
both products inserted into cell membranes and perturbed
their integrity (panel A). However, only E1C-expressing cells
were permeable to hygromycin B (panel B). Thus, lysis and
permeabilization were uncoupled events, the former most
likely leading to cell death and protein synthesis abolition,
while the latter was speciﬁcally determined in the viable cell
subpopulation that still performed metabolic functions. Since
hygromycin B entry was speciﬁcally measured for protein-
expressing viable cells, permeabilization must be a direct and
speciﬁc eﬀect of E1C. The results shown in Fig. 3 also suggest
that it is the combination of preTM and TMD sequences that
renders the membrane-permeabilizing motif of E1 glycopro-
tein. This hypothesis is supported by the fact that expression of
a product encoding E1 residues 323–417 (i.e., including the
preTM region but not the TMD) was not lytic and did not
permeabilize cells towards hygromycin B (data not shown).
Interestingly, the TME1 product (25 amino acids) migrated
as two bands in SDS–PAGE with apparent molecular weights
lower and higher than that of E1C (47 amino acids). The high
molecular weight band corresponds to higher order SDS-Fig. 3. Comparison of lytic and permeabilizing activities of E1C and TME1 p
carrying the pET11.TME1 (white symbols) or pET11.E1C (black symbols)
induction (arrows) to determine OD at 660 nm. The absorbance measured at
and its inhibition by hygromycin B entry.resistant oligomers. Thus, it is conceivable that membrane
oligomerization through this domain might well constitute an
important event during the functional E1 cycle.
Finally, we compared membrane activities of the two in-
tegral SFV sequences described to contain an interfacial
segment preceding the bilayer-spanning domain. In previous
work, we proposed this particular membrane topology for
6K based on its hydrophobicity distribution and suggested
its involvement in plasma membrane permeabilization during
alphavirus infection [17]. The analysis in Fig. 1 and results in
Fig. 2 suggest a similar structure-function relationship for
E1C. In Fig. 4, we show the kinetics of cell lysis and per-
meabilization induced by the expression of the E1C moiety
and 6K SFV products. In general, induction of both prod-
ucts was lytic for cultures (panel A) and enhanced mem-
brane permeability to uridine (panel B) and choline (panel
C). Main diﬀerences were noted in uridine release, such that
E1C was more active than 6K. This diﬀerence was not ob-
served for choline, possibly suggesting slight variations be-
tween the permeating structures. Hence, from the results in
Fig. 4, it might be inferred that both SFV products have
comparable capacities to permeabilize membranes upon their
expression.
3.1. Concluding remarks
Two groups of virus-encoded proteins, that interact with
membranes, capable of enhancing cell membrane permeability
have been described: viral glycoproteins [1,2,35], with a par-
ticular architecture in their TM regions and sequences proxi-
mal to this domain [21,36]; and viroporins, which include a
number of small, very hydrophobic integral membrane pro-
teins [1,23,37]. Despite there being little homology in their
primary structure, hydrophobicity distributions along se-
quences indicate a structural paradigm that might be related to
the membrane-activity of some of these proteins, i.e., per-
meabilizing units consist of integral membrane oligomers
composed of membrane-interface residing stretches that are
followed by TM anchors. In the case of 6K, we described that
interfacial elements, although not required for membrane-
association, appear to confer the ability to permeabilizeroducts. (A) Lysis in cultures of induced BL21(DE3) pLysS E. coli cells
constructions. 1-ml culture samples were taken at various times post-
30 min post-induction was taken as 100% value. (B) Protein synthesis
Fig. 4. Comparison of lytic and permeabilizing activities of E1C and 6K products. (A) Lysis in cultures of induced BL21(DE3) pLysS E. coli cells
carrying the pET11.6K (squares) or pET11.E1C (black circles) constructions. 1-ml culture samples were taken at various times post-induction to
determine OD at 660 nm. The absorbance measured at the time of induction was taken as the 100% value. Expression of XA was used as control
(white circles). (B) Uridine release upon induction. Cultures of bacteria were pre-loaded with 2 lCi/ml [3H]uridine prior to induction. At diﬀerent
post-induction times, the amount of radioactivity released to the medium was determined. Symbols as for the previous panel. (C) Idem, but cells were
preloaded with ½3Hcholine.
J.L. Nieva et al. / FEBS Letters 576 (2004) 417–422 421membranes [17]. The present results establish a common trait
for the stem-TM region of E1.
We could divide animal viruses into two groups according to
the presence or absence of a typical viroporin gene in their
genome. Those viruses that code for a viroporin may also
contain a glycoprotein with the capacity to alter membrane
permeability. Thus, in this case, it may be possible that
membrane leakiness at late times of infection is provoked in a
redundant manner by two diﬀerent types of molecules: viro-
porins and glycoproteins. Another possibility is that glyco-
proteins only exhibit their permeabilization capacity at early
stages of infection, while late permeabilization is mainly pro-
voked by viroporin functioning. In virus species with no evi-
dent viroporin gene, other viral molecules might take on their
function. For instance, this may be the case for HIV-2 that
does not encode the viroporin Vpu, while its TM glycoprotein
gp41 is endowed with permeabilizing capacity [22,38]. Other
animal viruses, such as Ebola virus, also lack a viroporin gene,
but contain glycoproteins that might enhance permeability
[24].
In conclusion, our understanding of the molecular basis of
membrane permeabilization by viroporins versus viral glyco-
proteins would beneﬁt much from the identiﬁcation of motifs
that participate in membrane eﬀects. In this regard, the ap-
proach presented in this work combining hydrophobicity dis-
tribution analysis (prediction) with expression-coupled
permeability assays (functional characterization) might be-
come a potent research tool. Nonetheless, it should be noted
that this approach relates to membrane-bound equilibrium
peptide structures. WW scales constitute a predictive tool be-
cause they can be used to identify protein sequences (even
those initially folded within globular domains) whose eventual
low-energy state is represented by a particular membrane-
bound structure [21–24]. Here, we predict that SFV E1 stem-
TM sequence in its low-energy conﬁguration adopts a 6K-like
permeabilizing membrane structure and expression-coupled
permeability assays in bacteria conﬁrm this prediction. Thus,
our data constitute a solid starting point for future mutagen-esis and structural analyses devoted to elucidate the mecha-
nism of membrane-insertion and subsequent pore-opening
within the context of the functional E1 protein.
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